2017
DOI: 10.1007/s11060-017-2468-y
|View full text |Cite
|
Sign up to set email alerts
|

Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC)

Abstract: Embryonal tumors are a heterogeneous group of central nervous system (CNS) tumors whose subgroups have varying incidence and outcome. Despite these differences, they are often grouped as a single entity for study purposes. To date, there are no Canadian multi-institutional studies examining the incidence and outcome of all embryonal subtypes. The current study is an observational study reviewing embryonal tumors in all patients less than 36 months of age diagnosed with a CNS tumor in Canada from 1990 to 2005. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…About one-third of patients with MB are under 3 years at diagnosis and 50% are under 5 years. [5][6][7] Following maximal safe surgical resection and proper staging with full magnetic resonance imaging of the brain and spine and cerebrospinal fluid cytopathology, the next critical step to allocate treatment heavily relies on the histopathological and molecular characterization of the MB.…”
Section: Not All Young Children Have High-risk Medulloblastomamentioning
confidence: 99%
“…About one-third of patients with MB are under 3 years at diagnosis and 50% are under 5 years. [5][6][7] Following maximal safe surgical resection and proper staging with full magnetic resonance imaging of the brain and spine and cerebrospinal fluid cytopathology, the next critical step to allocate treatment heavily relies on the histopathological and molecular characterization of the MB.…”
Section: Not All Young Children Have High-risk Medulloblastomamentioning
confidence: 99%